Sommerer, Claudia
Zeier, Martin
Morath, Christian
Reiser, Jochen
Scharnagl, Hubert
Stojakovic, Tatjana
Delgado, Graciela E.
März, Winfried
Kleber, Marcus E. http://orcid.org/0000-0003-0663-7275
Article History
Received: 26 June 2018
Accepted: 23 November 2018
First Online: 24 January 2019
Competing Interests
: C.S., M.Z., C.M., H.S., T.S., G.E.D., W.M. and M.E.K. have no conflicts of interest to report concerning the present publication. Jochen Reiser is co-founder of TRISAQ, a bio-pharmaceutical company that targets suPAR. He has stock and stands to gain royalties from commercialization.